Disclosures for "RNA profiles to distinguish multiple sclerosis (MS) and neuromyelitis optica (NMO) in peripheral whole blood")
-
Dr. Wylezinski has received personal compensation for serving as an employee of Decode Health. Dr. Wylezinski has stock in Decode Health. The institution of Dr. Wylezinski has received research support from Decode Health. Dr. Wylezinski has received intellectual property interests from a discovery or technology relating to health care.
-
Mrs. Shaginurova has nothing to disclose.
-
Dr. Grigorenko has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Decode Health. Dr. Grigorenko has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lifetime Sciences. Dr. Grigorenko has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharmozyme.
-
Dr. Wohlgemuth has received personal compensation for serving as an employee of Quest Diagnostics. Dr. Wohlgemuth has stock in Quest Diagnostics.
-
Dr. Cockerill has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Quest Diagnostics. Dr. Cockerill has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mainz Biotech. Dr. Cockerill has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Imanis Life Sciences. Dr. Cockerill has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Scanwell. Dr. Cockerill has received personal compensation in the range of $0-$499 for serving as a Consultant for Visby. Dr. Cockerill has received personal compensation in the range of $0-$499 for serving as a Consultant for Microbiobloc. Dr. Cockerill has received personal compensation in the range of $0-$499 for serving as a Consultant for Decode Health. An immediate family member of Dr. Cockerill has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Quest Diagnostics . Dr. Cockerill has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Magnolia Medical Technologies. Dr. Cockerill has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for 98point6. Dr. Cockerill has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Decode Health. An immediate family member of Dr. Cockerill has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Online MedED. Dr. Cockerill has stock in ACLIP. Dr. Cockerill has stock in Magnolia Medical Technologies. An immediate family member of Dr. Cockerill has stock in Online Med Ed. Dr. Cockerill has stock in Visby. Dr. Cockerill has stock in 98point6. Dr. Cockerill has stock in Mainz Biomed. Dr. Cockerill has stock in Microbiobloc. Dr. Cockerill has stock in Decode Health. Dr. Cockerill has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Racke has received personal compensation for serving as an employee of Quest Diagnostics. An immediate family member of Dr. Racke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Racke has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. An immediate family member of Dr. Racke has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
-
Dr. Spurlock has received personal compensation for serving as an employee of Decode Health. Dr. Spurlock has received personal compensation for serving as an employee of New York University. Dr. Spurlock has received personal compensation for serving as an employee of IQuity Labs. Dr. Spurlock has stock in Decode Health. Dr. Spurlock has stock in IQuity Labs. The institution of Dr. Spurlock has received research support from National Institutes of Health.